Class information for:
Level 1: DANISH NURSE COHORT//EPES EPIDEMIOL//BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
6515 1406 39.4 68%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
754 11793 MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 DANISH NURSE COHORT Address 3 100% 0% 3
2 EPES EPIDEMIOL Address 3 60% 0% 3
3 BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST Author keyword 2 67% 0% 2
4 BREAST TUMOR ABORAT STUDY Address 2 67% 0% 2
5 CONTINUOUS INCUBATION Author keyword 2 67% 0% 2
6 ESTROGEN DEFICIENCY SYMPTOMS Author keyword 2 67% 0% 2
7 ESTROGEN ONLY THERAPY Author keyword 2 67% 0% 2
8 MRC BHF CLIN TRIAL SERV UNIT Address 2 67% 0% 2
9 RISK FACTORS FOR BREAST CANCER Author keyword 2 67% 0% 2
10 STEROID CONCENTRATION Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 BENIGN PROLIFERATIVE EPITHELIAL DISORDERS OF THE BREAST 2 67% 0% 2 Search BENIGN+PROLIFERATIVE+EPITHELIAL+DISORDERS+OF+THE+BREAST Search BENIGN+PROLIFERATIVE+EPITHELIAL+DISORDERS+OF+THE+BREAST
2 CONTINUOUS INCUBATION 2 67% 0% 2 Search CONTINUOUS+INCUBATION Search CONTINUOUS+INCUBATION
3 ESTROGEN DEFICIENCY SYMPTOMS 2 67% 0% 2 Search ESTROGEN+DEFICIENCY+SYMPTOMS Search ESTROGEN+DEFICIENCY+SYMPTOMS
4 ESTROGEN ONLY THERAPY 2 67% 0% 2 Search ESTROGEN+ONLY+THERAPY Search ESTROGEN+ONLY+THERAPY
5 RISK FACTORS FOR BREAST CANCER 2 67% 0% 2 Search RISK+FACTORS+FOR+BREAST+CANCER Search RISK+FACTORS+FOR+BREAST+CANCER
6 STEROID CONCENTRATION 2 67% 0% 2 Search STEROID+CONCENTRATION Search STEROID+CONCENTRATION
7 TUMOUR RISK 2 67% 0% 2 Search TUMOUR+RISK Search TUMOUR+RISK
8 ESTROGEN PROGESTIN THERAPY 2 36% 0% 4 Search ESTROGEN+PROGESTIN+THERAPY Search ESTROGEN+PROGESTIN+THERAPY
9 MENOPAUSAL HORMONE THERAPY 2 14% 1% 11 Search MENOPAUSAL+HORMONE+THERAPY Search MENOPAUSAL+HORMONE+THERAPY
10 BREAST EPITHELIAL PROLIFERATION 1 100% 0% 2 Search BREAST+EPITHELIAL+PROLIFERATION Search BREAST+EPITHELIAL+PROLIFERATION

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 MENOPAUSAL ESTROGEN 47 66% 3% 44
2 MENOPAUSAL ESTROGENS 23 69% 1% 20
3 EXOGENOUS ESTROGENS 23 53% 2% 31
4 PROGESTIN REPLACEMENT 20 62% 1% 21
5 DIFFERENT REGIMENS 17 59% 1% 19
6 EXPANDED CASE CONTROL 15 88% 0% 7
7 SCREENING MAMMOGRAPHY POPULATION 15 88% 0% 7
8 ESTROGEN PROGESTIN REPLACEMENT 12 17% 4% 62
9 POSTMENOPAUSAL CYNOMOLGUS MACAQUES 8 75% 0% 6
10 PROGESTIN REPLACEMENT THERAPY 7 35% 1% 16

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Lobular breast cancer: incidence and genetic and non-genetic risk factors 2015 1 100 30%
A METAANALYSIS OF THE EFFECT OF ESTROGEN REPLACEMENT THERAPY ON THE RISK OF BREAST-CANCER 1991 538 43 63%
Changing Concepts: Menopausal Hormone Therapy and Breast Cancer 2012 38 90 44%
Breast cancer risk with postmenopausal hormonal treatment 2005 78 70 63%
Hormone replacement therapy and the risk of breast cancer 2011 38 48 46%
Hormone replacement therapy and breast cancer: A qualitative review 2001 95 86 79%
MENOPAUSAL HORMONE REPLACEMENT THERAPY AND BREAST-CANCER - A METAANALYSIS 1992 172 46 70%
Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review 2013 21 94 31%
Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis 2006 65 110 68%
The incidence of breast cancer and changes in the use of hormone replacement therapy: A review of the evidence 2009 23 40 75%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 DANISH NURSE COHORT 3 100% 0.2% 3
2 EPES EPIDEMIOL 3 60% 0.2% 3
3 BREAST TUMOR ABORAT STUDY 2 67% 0.1% 2
4 MRC BHF CLIN TRIAL SERV UNIT 2 67% 0.1% 2
5 ENDOCRINOL MENOPAUSE 1 19% 0.5% 7
6 FRENCH MULTI BREAST STUDY 1 100% 0.1% 2
7 GRP GYNECOLOGISTS OBSTETRICIANS GENEVA 1 100% 0.1% 2
8 TEACHING HOSP GYNAECOL OBSTET 1 100% 0.1% 2
9 ARCADES 1 40% 0.1% 2
10 DISCIPLINE GYNECOL 1 40% 0.1% 2

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000215023 WOMENS HEALTH INITIATIVE//INTERDISCIPLINARY GRP OSTEOPOROSIS//WHI STUDY
2 0.0000193073 REPRODUCTIVE FACTORS//AGE AT FIRST FULL TERM PREGNANCY//AGE AT LAST BIRTH
3 0.0000159627 ENDOMETRIAL SAFETY//TRIMEGESTONE//CAS 53 16 7
4 0.0000154778 TIBOLONE//TIBOLONE METABOLITES//LIVIAL
5 0.0000145837 MAMMOGRAPHIC DENSITY//BREAST DENSITY//MAMMOGRAPHIC BREAST DENSITY
6 0.0000121584 MOLECULAR APOCRINE//DAME ROMA MITCHELL CANC S//ESTROGEN RECEPTOR NEGATIVE
7 0.0000113903 CEITOX//BREAST CELL CARCINOGENESIS//POL III GENES
8 0.0000110663 PROGESTERONE RECEPTOR ISOFORMS//PROGINS//PROGESTERONE RECEPTOR A
9 0.0000097117 FERTILITY DRUGS//OVARIAN NEOPLASMS//INCESSANT OVULATION
10 0.0000091939 HORMONE REPLACEMENT THERAPY//HORMONE THERAPY//TIMING HYPOTHESIS